Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer.
Schofield PE, Stockler MR, Zannino D, Tebbutt NC, Price TJ, Simes RJ, Wong N, Pavlakis N, Ransom D, Moylan E, Underhill C, Wyld D, Burns I, Ward R, Wilcken N, Jefford M. Schofield PE, et al. Among authors: zannino d. Support Care Cancer. 2016 Jan;24(1):401-408. doi: 10.1007/s00520-015-2792-8. Epub 2015 Jun 21. Support Care Cancer. 2016. PMID: 26093975 Clinical Trial.
Long-term cardiovascular consequences of adolescent anorexia nervosa.
Springall GAC, Caughey M, Zannino D, Kyprianou K, Mynard JP, Rudolph S, Cheong J, Yeo M, Cheung MMH. Springall GAC, et al. Among authors: zannino d. Pediatr Res. 2023 Oct;94(4):1457-1464. doi: 10.1038/s41390-023-02521-5. Epub 2023 Feb 15. Pediatr Res. 2023. PMID: 36792652 Free PMC article.
Arterial structure and function in children with inflammatory bowel disease.
Jois A, Zannino D, Catto-Smith AG, Kaegi M, Mynard JP, Rosenbaum J, Oliver M, Hardikar W, Alex G, Burgner D. Jois A, et al. Among authors: zannino d. JGH Open. 2024 Jun 3;8(6):e13100. doi: 10.1002/jgh3.13100. eCollection 2024 Jun. JGH Open. 2024. PMID: 38832138 Free PMC article.
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
Tebbutt NC, Wilson K, Gebski VJ, Cummins MM, Zannino D, van Hazel GA, Robinson B, Broad A, Ganju V, Ackland SP, Forgeson G, Cunningham D, Saunders MP, Stockler MR, Chua Y, Zalcberg JR, Simes RJ, Price TJ. Tebbutt NC, et al. Among authors: zannino d. J Clin Oncol. 2010 Jul 1;28(19):3191-8. doi: 10.1200/JCO.2009.27.7723. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516443 Clinical Trial.
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab.
Tebbutt NC, Murphy F, Zannino D, Wilson K, Cummins MM, Abdi E, Strickland AH, Lowenthal RM, Marx G, Karapetis C, Shannon J, Goldstein D, Nayagam SS, Blum R, Chantrill L, Simes RJ, Price TJ; Australasian Gastro-Intestinal Trials Group. Tebbutt NC, et al. Among authors: zannino d. Ann Oncol. 2011 Aug;22(8):1834-8. doi: 10.1093/annonc/mdq702. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273347 Free article. Clinical Trial.
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
Stockler MR, Harvey VJ, Francis PA, Byrne MJ, Ackland SP, Fitzharris B, Van Hazel G, Wilcken NR, Grimison PS, Nowak AK, Gainford MC, Fong A, Paksec L, Sourjina T, Zannino D, Gebski V, Simes RJ, Forbes JF, Coates AS. Stockler MR, et al. Among authors: zannino d. J Clin Oncol. 2011 Dec 1;29(34):4498-504. doi: 10.1200/JCO.2010.33.9101. Epub 2011 Oct 24. J Clin Oncol. 2011. PMID: 22025143 Clinical Trial.
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.
Price TJ, Zannino D, Wilson K, Simes RJ, Cassidy J, Van Hazel GA, Robinson BA, Broad A, Ganju V, Ackland SP, Tebbutt NC. Price TJ, et al. Among authors: zannino d. Ann Oncol. 2012 Jun;23(6):1531-6. doi: 10.1093/annonc/mdr488. Epub 2011 Oct 29. Ann Oncol. 2012. PMID: 22039086 Free article. Clinical Trial.
Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial.
Tebbutt NC, Parry MM, Zannino D, Strickland AH, Van Hazel GA, Pavlakis N, Ganju V, Mellor D, Dobrovic A, Gebski VJ; Australasian Gastro-Intestinal Trials Group (AGITG). Tebbutt NC, et al. Among authors: zannino d. Br J Cancer. 2013 Mar 5;108(4):771-4. doi: 10.1038/bjc.2013.41. Epub 2013 Feb 14. Br J Cancer. 2013. PMID: 23412099 Free PMC article. Clinical Trial.
108 results